Previous 10 | Next 10 |
The shares of health equipment maker Ekso Bionics Holdings (NASDAQ:EKSO) added ~28% in the pre-market Monday after the company announced that the FDA issued 510(k) clearance for EksoNR robotic exoskeleton for use in multiple sclerosis (MS) patients. EksoNR is a CE-marked product ava...
Day One Biopharmaceuticals (DAWN) +81% announces positive initial data from pivotal FIREFLY-1 trial of Tovorafenib (DAY101) in relapsed pediatric low-grade Glioma. Redbox Entertainment (RDBX) +30%. Ekso Bionics Holdings (EKSO) +22% receives FDA clearance to market its EksoNR Robotic...
First FDA Cleared Exoskeleton for Rehabilitation Use in Patients with Multiple Sclerosis RICHMOND, Calif., June 13, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industr...
Ekso Bionics Holdings (NASDAQ:EKSO) on Thursday announced the appointment of Jerome Wong as the company's interim chief financial officer, effective immediately. It comes after current CFO Jack Glenn resigned effective June 17, 2022 to pursue a new position at another public company. Won...
RICHMOND, Calif., May 26, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced the appointment of Jerome Wong as Interim Chief Financial Officer followi...
RICHMOND, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that management will present at the H.C. Wainwright Global Investment Conference taking place May 23-26...
The following slide deck was published by Ekso Bionics Holdings, Inc. in conjunction with this event. For further details see: Ekso Bionics (EKSO) Investor Presentation - Slideshow
Ekso Bionics Holdings, Inc. (EKSO) Q1 2022 Earnings Conference Call April 28, 2022 4:30 PM ET Company Participants Steven Sherman - Chairman & CEO Scott Davis - President & Chief Operating Officer Jack Glenn - CFO Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright D...
RICHMOND, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended March 31, 2022. Rec...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Another day of investing awaits as we start it off with a breakdown of the biggest pre-market stock movers for Monday! Source: ventdusud / Shutterstock.com Moving stocks this morning is special dividend news, a manu...
News, Short Squeeze, Breakout and More Instantly...
Ekso Bionics Holdings Inc. Company Name:
EKSO Stock Symbol:
NASDAQ Market:
Ekso Bionics Holdings Inc. Website:
SAN RAFAEL, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2...
Collaboration Expands Use of EksoNR and Ekso Indego Devices in Rehabilitation and Community Settings to Better Improve Patient Quality of Life SAN RAFAEL, Calif., June 25, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso...
Brings Strategic Healthcare Expertise and Extensive Experience with the U.S. Department of Veterans Affairs (VA) to Ekso’s Board Deborah Lafer Scher SAN RAFAEL, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”...